** Shares of chemicals maker Chemours CC.N up 3.1% at $17.35 premarket

** Company posts smaller Q4 loss of $8 million compared to $18 million a year ago

** Co says it has fully addressed all four material weaknesses in internal control previously identified in the 2023 Form 10-K

** CC expects consolidated net sales to be flat to slightly down sequentially in Q1

** YTD shares down 0.41% as of last close

(Reporting by Katha Kalia)

((Katha.Kalia@thomsonreuters.com))